Trial Profile
Effects of edaravone in patients with acute myocardial infarction
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Edaravone (Primary)
- Indications Myocardial infarction
- Focus Therapeutic Use
- 14 Feb 2008 The expected completion date for this trial is now 1 Jun 2007.
- 15 Nov 2007 Status changed from recruiting to completed.
- 28 Oct 2006 New trial record.